Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

3 recruiting1 with results

Enrollment Performance

Analytics

Phase 1

2(40.0%)

Phase 3

1(20.0%)

N/A

1(20.0%)

Phase 2

1(20.0%)

5Total

Phase 1(2)

Phase 3(1)

N/A(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT05576948Recruiting

Natural History of Cerebral Palsy Prospective Study

Role: collaborator

NCT05651347Phase 3Recruiting

Antenatal Melatonin Supplementation for Neuroprotection in Fetal Growth Restriction

Role: collaborator

NCT05197946Recruiting

Anatomical and Functional Imaging Correlates of Chronic Pain in Cerebral Palsy

Role: collaborator

NCT05171881Phase 2Active Not Recruiting

Brain Oxygenation-II

Role: collaborator

NCT03230032Not ApplicableCompleted

Pacifier Activated Device and Mother's Voice in Infants at High-risk for Cerebral Palsy

Role: collaborator

NCT04537351Phase 1Completed

The MEseNchymal coviD-19 Trial: MSCs in Adults With Respiratory Failure Due to COVID-19 or Another Underlying Cause

Role: collaborator

NCT02743728Completed

Perinatal Stroke: Understanding Brain Reorganization

Role: collaborator

NCT03087110Phase 1Completed

Stem Cells in Umbilical Blood Infusion for CP

Role: collaborator

All 8 trials loaded